Global Medical REIT adopts amended bylaws to comply with federal proxy rules

Chiron Real Estate Inc.

Board adopted Fourth Amended and Restated Bylaws effective December 7, 2022, to ensure compliance with Rule 14a-19 under the Exchange Act.
Stockholders soliciting proxies must use a proxy card color other than white; white proxy card reserved for Board use.
Director nomination notices must now include a written undertaking to solicit holders of at least 67% voting power.
Company may disregard proxy authority for any nominee if the soliciting stockholder abandons or fails to comply with Rule 14a-19.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Chiron Real Estate Inc.: Board approved and adopted Fourth Amended and Restated Bylaws to ensure compliance with federal proxy rules, including Rule 14a-19, among other administrative amendments (effective 2022-12-07).

Change: bylaw amendment
Effective: 2022-12-07

Exact text from the filing

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. At a meeting of the Board of Directors (the “Board”) of Global Medical REIT Inc., a Maryland corporation (the “Company”), held on December 7, 2022, the Board approved and adopted effective as of such date the Fourth Amended and Restated Bylaws of the Company (the “Amended and Restated Bylaws”), amending certain provisions to ensure compliance with the federal proxy rules, including Rule 14a-19 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), among other administrative amendments.

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

Chiron Real Estate Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-125184

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.